Cornell is one of only seven institutions across the U.S. that will receive a funding award from the National Institutes of Health through a program aimed at increasing minority faculty in the biomedical sciences.
On Sept. 24, after a year highlighted by so many virtual events, the Class of 2024 finally celebrated their medical school journey with a White Coat Ceremony – hosted in-person.
Simulations show the helmet, designed by the Esmaily Lab, prevents 99.6% of virus-containing droplets exhaled by medical patients from reaching the environment.
COVID-19 vaccination of expectant mothers elicits levels of antibodies to the SARS-CoV-2 outer “spike” protein at the time of delivery that don’t vary dramatically with the timing of vaccination during pregnancy and thus don’t justify delaying vaccination, according to a study from researchers at Weill Cornell Medicine.
During National Public Health Week April 5-11, up to 10,000 seats are available in the new Citizen Public Health Leader Training Program developed by Cornell experts in partnership with New York state.
K-12 schools across the country are closing or moving to online education to help control the spread of the coronavirus. Jamila Michener, assistant professor of government says during times of public health crisis the consequences of inequalities surface and it’s going to be a huge challenge to support K-12 students facing school closures at home and also in their communities.
As a CIFAR Azrieli Global Scholars, Baobao Zhang will investigate challenges governments face when addressing public perceptions of inequalities brought about by new technologies and Elizabeth Johnson will look into connections between infant nutrition and gastrointestinal health.
A new strategy for developing vaccines against cancer showed promise in a proof-of-concept study led by scientists at Weill Cornell Medicine, NewYork-Presbyterian and Heidelberg University Hospital.
Immune cells called group 3 innate lymphoid cells play an essential role in establishing tolerance to symbiotic microbes that dwell in the human gastrointestinal tract, according to a study led by researchers at Weill Cornell Medicine.
Embark Veterinary, Inc. – a canine genetics startup company that graduated from Cornell’s McGovern Center incubator in late 2017 – announced $75 million in venture funding on July 26.
